Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.39 |
| ▸ | ANPEP | P15144 | 7/20 | 0.38 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.38 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 4/20 | 0.37 |
| ▸ | LAP3 | P28838 | 2/20 | 0.34 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.34 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31537744 | 0.82 | SLC7A5 (0.48) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL24575864 | 0.76 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL16142371 | 0.76 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| SCHEMBL18678835 | 0.76 | SLC7A5 (0.56) | SLC7A5SLC1A3SLC1A2ANPEPRNPEP | |
| Leucine SCHEMBL29071605 | 0.73 | SLC7A5 (0.72) | SLC7A5SLC1A3SLC1A2RNPEPSLC1A1 | |
| SCHEMBL28914598 | 0.72 | — | — | |
| SCHEMBL28785292 | 0.72 | NOS1 (0.30) | — | |
| SCHEMBL30660942 | 0.72 | NOS1 (0.30) | — | |
| SCHEMBL29233148 | 0.72 | ALDH1A1 (0.37) | LAP3ALDH1A1 | |
| SCHEMBL4459591 | 0.69 | GRM8 (0.34) | SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037122-A | Optical film precoating resin and preparation process method of composite film thereof | 合肥科天水性科技有限责任公司 | 2026-05-15 | — | — | CN | claimed |
| CN-115667215-B | Broad-spectrum antiviral medicine for resisting coronavirus | 堪萨斯州立大学研究基金会 | 2026-05-19 | — | — | CN | disclosed |
| CN-122037122-A | Optical film precoating resin and preparation process method of composite film thereof | 合肥科天水性科技有限责任公司 | 2026-05-15 | — | — | CN | disclosed |
| US-12590123-B2 | Compounds and methods for treating cancer, viral infections, and allergic conditions | WASHINGTON UNIVERSITY (US) | 2026-03-31 | — | — | US | disclosed |
| US-12583820-B2 | Broad spectrum antivirals against coronavirus | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2026-03-24 | — | — | US | disclosed |
| US-12180156-B2 | Deuterated protease inhibitors | KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2024-12-31 | — | — | US | disclosed |
| CN-116425944-A | Preparation method of bio-based aqueous polyurethane, PET coating film and optical reflection base film | 合肥科天水性科技有限责任公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116284661-A | Water-based bio-based polyurethane resin, degradable synthetic leather and preparation method thereof | 合肥科天水性科技有限责任公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4126816-A1 | BROAD SPECTRUM ANTIVIRALS AGAINST CORONAVIRUS | Kansas State University Research Foundation (US) | 2023-02-08 | — | — | EP | disclosed |
| CN-115667215-A | Broad-spectrum antiviral medicine for resisting coronavirus | 堪萨斯州立大学研究基金会 | 2023-01-31 | — | — | CN | disclosed |
| US-20220380407-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER, VIRAL INFECTIONS, AND ALLERGIC CONDITIONS | WASHINGTON UNIVERSITY (US) | 2022-12-01 | — | — | US | disclosed |
| EP-3989997-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER, VIRAL INFECTIONS, AND ALLERGIC CONDITIONS | Washington University (US) | 2022-05-04 | — | — | EP | disclosed |
| WO-2020264187-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER, VIRAL INFECTIONS, AND ALLERGIC CONDITIONS | JANETKA JAMES (US) | 2020-12-30 | — | — | WO | disclosed |
| CN-103739642-A | Carbamate derivates of scutellarin and seutellarein, and application thereof | UNIV GUIYANG MEDICAL | 2014-04-23 | — | — | CN | disclosed |
| US-6423519-B1 | CONTACTING FUNGAL CELL WITH COMPOUND WHICH INHIBITS PRENYLTRANSFERASE ACTIVITY OF CELL, INCLUDING PERMEASE TAG WHICH FACILITATES PERMEASE-MEDIATED TRANSPORT OF COMPOUND INTO CELL, INHIBITING GROWTH THEREOF | GPC BIOTECH INC. | 2002-07-23 | — | — | US | disclosed |
| EP-1096925-A2 | USE OF INHIBITORS OF PRENYLTRANSFERASES FOR FOR INHIBITING FUNGAL GROWTH | MITOTIX, INC. (US) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000003743-A9 | USE OF INHIBITORS OF PRENYLTRANSFERASES FOR INHIBITING FUNGAL GROWTH | MITOTIX INC (US) | 2000-07-27 | — | — | WO | disclosed |
| WO-2000003743-A2 | USE OF INHIBITORS OF PRENYLTRANSFERASES FOR INHIBITING FUNGAL GROWTH | MITOTIX, INC. (US) | 2000-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583820-B2 | Broad spectrum antivirals against coronavirus | SARS1, NSUN2, ZC3HAV1 | SLC7A5 852/4885SLC1A3 1759/4885SLC1A2 3305/4885 |
| US-12180156-B2 | Deuterated protease inhibitors | ACE, CTRL, DPP4 | SLC7A5 1991/4885SLC1A3 3937/4885SLC1A2 4642/4885 |
| US-12590123-B2 | Compounds and methods for treating cancer, viral infections, and allergic conditions | TMPRSS2, TMPRSS4, F2RL3 | SLC7A5 1719/4885SLC1A3 3992/4885SLC1A2 4216/4885 |
| US-20220380407-A1 | COMPOUNDS AND METHODS FOR TREATING CANCER, VIRAL INFECTIONS, AND ALLERGIC CONDITIONS | TMPRSS2, PRSS1, PRSS2 | SLC7A5 2215/4885SLC1A3 4219/4885SLC1A2 4552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.